• SENSEX 73,377.24
    -229.51 (--0.31%)
  • BANKNIFTY 54,366.70
    79.35 (+0.15%)
  • TVS Holdings
    11,337.15 16,150.00(%)
  • NSE
    1,774.00 1,878.00(%)
  • Ather Energy
    1,702.00 1,741.90(%)
  • Apollo Micro Sys
    446.80 466.70(%)
  • LIC Housing Fin.
    512.00 598.00(%)
  • DLF
    672.55 786.40(%)
  • Persistent Systems
    5,695.50 4,242.65(%)
  • Sona BLW Precis.
    863.90 843.90(%)
  • Adani Enterp.
    2,434.60 1,753.45(%)
  • Federal Bank
    348.20 364.95(%)
  • Reliance Industries
    1,184.00 1,152.30(%)
  • OneSource Speci.
    1,606.35 1,924.00(%)
  • Sky Gold & Diam.
    965.00 1,083.00(%)
  • HDFC Bank
    680.15 682.00(%)
  • SBI Life Insuran
    1,626.75 1,609.20(%)
  • Torrent Pharma.
    4,649.20 5,249.95(%)
  • Tonbo Imaging
    1,300.00 1,331.45(%)
  • Max Healthcare
    857.00 1,196.50(%)
  • GE Vernova T&D
    4,025.00 5,650.00(%)
  • NTPC
    306.70 414.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Trident Lifeline Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 77345.0
  • ISIN : INE0MKA01014
416.95 10 (2.44%)
  • As on 27 Oct 2026 (EOD)

  • Today’s Low

    406.00

  • Today’s High

    418.95

  • Open

    413.70

  • Perv Close

    407.00

  • 52W Low

    229.95

  • 52W High

    425.00

Key Indicators

  • P/E(TTM)

    25.44

  • Mar.Cap (₹Cr.)

    499.55

  • Div & Yield %

    0.00

  • Book Value(₹)

    80.66

  • Debt-Equity Ratio

    2.44

  • AGM Date

    26-Oct-2026

  • EPS

    16.39

  • P/E Ratio

    25.44

Financials Ratios

  • Debt-Equity Ratio

    0.26

  • Mar.Cap (₹Cr.)

    499.55

  • RONW (%)

    12.06

  • ROCE (%)

    14.99

Score Board

  • Equity (₹ in Cr.)

    11.98

  • BV (₹)

    80.70

  • Sales( ₹ in Cr.)

    101.90

  • NP (in Cr.)

    18.10

  • NP Var(%)

    39.0

  • Div%

    0.0

  • CPS (₹)

    16.70

  • EPS (₹)

    15.10

  • Traded Value (₹ in Lakhs)

    499.55

  • 52 Week High

    425.00

  • 52 Week Low

    229.95

  • Price BSE

    417.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    499.55

  • P/C Ratio

    25.00

  • P/E Ratio

    27.60

  • Price Vs.BV

    15.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 101.90 67.80 44.65 31.69 21.77 9.62
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 101.90 67.80 44.65 31.69 21.77 9.62
Other Income 4.17 3.14 2.20 1.15 0.60 0.16
Stock Adjustments 1.95 -1.47 0.67 2.89 0.46 0.41
Total Income 108.02 69.47 47.52 35.73 22.83 10.19
EXPENDITURE :            
Raw Materials 64.23 34.74 30.23 23.12 14.69 5.92
Power and Fuel Cost 0.23 0.14 0.07 0.03 0.02 0.02
Employee Cost 2.94 2.51 1.55 1.39 1.10 0.70
Other Manufacturing Expenses 7.99 8.73 2.54 2.38 2.66 1.29
Selling and Administration Expenses 2.92 1.76 1.36 0.98 0.94 0.83
Miscellaneous Expenses 1.19 0.79 0.70 0.42 0.11 0.01
Employee Benefit Expenses 2.94 2.51 1.55 1.39 1.10 0.70
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 79.50 48.66 36.45 28.33 19.52 8.78
Operating Profit 28.52 20.81 11.08 7.42 3.32 1.41
Interest 1.68 1.38 0.51 0.48 0.13 0.41
Gross Profit 26.84 19.43 10.57 6.94 3.19 1.00
Depreciation 1.86 1.53 0.77 0.36 0.20 0.14
Profit Before Tax 24.98 17.90 9.80 6.58 2.99 0.86
Current Tax 6.40 4.25 2.38 0.04 -0.14 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.49 0.60 0.37 0.52 -0.82 0.22
Reported Net Profit 18.09 13.05 7.04 6.01 3.95 0.63
Extraordinary Items -0.01 0.00 0.01 0.00 0.00 0.00
Adjusted Net Profit 18.10 13.05 7.03 6.01 3.95 0.63
Adjustment below Net Profit 0.00 0.00 0.00 -0.50 0.00 -0.63
P & L Balance brought forward 22.38 9.33 2.29 -3.22 -7.17 -6.10
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 -0.63
P & L Balance carried down 40.48 22.38 9.33 2.29 -3.22 -5.47
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 15.16 11.35 6.13 5.23 4.93 1.26
Earnings Per Share(Adj)-Unit Curr 15.16 11.35 6.13 5.23 - -
Book Value 79.91 57.16 45.81 39.68 5.97 -0.94
Book Value(Adj)-Unit Curr 79.91 57.16 45.81 39.68 - -

Shareholding Pattern

  • Promoter Group

    62.54%

  • Public Share Holding

    37.46%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 65,200 65,200.00 65,200 65,200
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 65,200 0.54 65,200 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 109,300 0.91 109,300 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 6,460,534 53.92 6,460,534 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 857,366 7.16 857,366 1
Others 0 0.00 0 0
Sub Total 7,427,200 61.99 7,427,200 12
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 138,600 1.16 138,600 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 25,200 0.21 25,200 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 163,800 1.37 163,800 5
2] Non Institution
Bodies Corporate 718,200 5.99 718,200 22
Clearing Members 436,800 3.65 436,800 85
Directors of their Relatives 90,600 0.76 90,600 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 22,200 0.19 22,200 15
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 45,600 0.38 45,600 4
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,141,800 9.53 1,141,800 28
Individuals holding nominal share capital up to Rs. 1 lakh 1,815,000 15.15 1,815,000 880
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 54,600 0.46 54,600 1
Sub Total 4,324,800 36.10 4,324,800 1,036
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 11,981,000 100.00 11,981,000 1,054

Company Background

Trident Lifeline LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Trident Lifeline Ltd
  • BSE Code : 77345.0
  • ISIN : INE0MKA01014

  • Incorporation Year

    2014

  • Registered Office

    2nd Floor Shop 2004 North Ext.
    Falsawadi Begumpura Nodh4/1650, Surat,
    Gujarat-395003

  • Telephone

    91-0261-2490224/8160276395

  • FAX

  • Chairman

    Hardik J Desai

  • Managing Director

    Shravan Harikrishna Patel

  • Company Secretary

    Nikita Sharma

  • Auditor

    A Bafna & Associates.

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Trident Lifeline Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Trident Lifeline 416.95 106.07 101.90 25.44 26.08
Abbott India 25,222.05 7,217.19 6,929.05 33.19 43.78
Astrazeneca Phar 6,074.75 2,304.07 2,275.58 89.53 27.86
Glaxosmi. Pharma 2,448.15 3,932.76 3,790.20 39.11 58.17
Novartis India 1,788.65 393.10 354.33 45.17 15.94
Cipla 1,353.00 20,102.60 18,979.95 35.56 13.88
Bliss GVS Pharma 617.15 773.53 729.81 57.36 12.51
Amrutanjan Healt 490.00 520.13 502.55 26.25 24.16
Fermenta Biotec. 445.65 474.15 450.25 20.81 18.77
Guj. Themis Bio. 337.75 168.25 165.82 90.31 18.05
Ambalal Sarabhai 35.99 19.52 3.94 66.65 6.77